Kilitch Healthcare India is voluntarily recalling the eye drop products listed in the table below to the consumer level with all lots within expiry with expiration dates ranging from November 2023 to September 2025 for all the below-mentioned products
Read MoreReportedly, Merck had submitted additional data after the FDA rejected the drug in January of the previous year
Read MoreThe U.S. Food and Drug Administration (FDA) has granted marketing authorisation to LetsGetChecked for the Simple 2 Test, the first-ever diagnostic test for chlamydia and gonorrhoea with at-home sample collection
Read MoreIn September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
Read MoreRocuronium Bromide Injection had estimated annual sales of USD 54 million in the U.S. according to IQVIA MAT, August 2023
Read MoreCanagliflozin plays a crucial role in reducing the risk of major adverse cardiovascular events, which encompasses cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke, in adults suffering from type 2 diabetes mellitus with established cardiovascular disease
Read MoreGlenmark’s Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg, will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA
Read MoreFDA laboratory analysis has uncovered that this product contains glyburide and metformin, both of which are active ingredients found in FDA-approved prescription medications designed for the treatment of type 2 diabetes
Read More